Loading data for EDSA — first visit, this takes a few seconds.

Alerta

Edesa Biotech Inc. (EDSA)

NasdaqCM: EDSA · Precio en tiempo real · USD

5.65

+0.30 (5.61%)

Al cierre: Aug 17, 2026, 8:00 PM

5.61% (1D)

No hay datos disponibles

Precio de compra	4.71
Capitalización de mercado	54.43M
Ingresos (TTM)	n/a
Beneficio neto (TTM)	-14.1M
Beta	n/a
EPS (TTM)	-1.83
Ratio PER (TTM)	n/a
Adelante PE	-2.93
P/B (TTM)	137.80
P/S (TTM)	n/a
Earnings Date	n/a

Precio de venta	7.23
Volumen	122,631
Volumen medio (20D)	158,419
Abierto	5.36
Anterior Cerrar	5.35
Rango del día	5.36 - 6.51
Rango de 52 semanas	0.72 - 20.32
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de EDSA

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has compl...

[Leer más]

Industria Biotechnology

Sector Healthcare

IPO Fecha Jun 21, 2010

Empleados 17

Bolsa de Valores NasdaqCM

Símbolo bursátil EDSA

Sitio web https://www.edesabiotech.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Edesa Biotech fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -7.19M, un aumento de 16.46%.

Estados financieros

Sorpresa de resultados

Edesa Biotech ha publicado sus resultados trimestrales en Aug 13, 2026:

Ingresos de $0 falla las estimaciones por $0, con NaN% Crecimiento interanual.

EPS de -0.6 falla las estimaciones por -0.17, con -140.00% Disminución interanual.

Noticias

2 meses hace · MT Newswires

Sector Update: Healthcare Stocks Gain Friday Afternoon

Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index increasing 1.2% and the Stat

2 meses hace · MT Newswires

Top Midday Stories: Lululemon Down After Fiscal Q1 Results; Amazon Engineers Criticize AI Spending; Hoffman to Exit Microsoft Board

All three major US stock indexes were down late Friday morning following a better-than-expected May

3 meses hace · Simply Wall St.

Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock Buying

Insiders who bought Edesa Biotech, Inc. ( NASDAQ:EDSA ) stock in the last 12 months were richly rewarded last week. The...

4 meses hace · Insider Monkey

Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment

Edesa Biotech Inc. (NASDAQ:EDSA) is one of the 10 Unstoppable Stocks That Could Double Your Money. Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On Ma...

5 meses hace · Associated Press Finance

BC-Most Active Stocks

Elong Power Holding Ltd. 49,425,228 0.49

Página 1 de 2

Edesa Biotech Inc. (EDSA)